According to an exclusive report by TOI, with USTR indicating American support only for talks on patent flexibility for vaccines at the WTO, the scope of the proposed waiver could turn out to be the next sticking point.
According to an exclusive report by TOI, with USTR indicating American support only for talks on patent flexibility for vaccines at the WTO, the scope of the proposed waiver could turn out to be the next sticking point.